Search the Newsreel

Redmile Group (SRRK) updates Scholar Rock stake to 3.6% of common stock

Redmile Group, LLC, Jeremy C. Green, and RedCo II Master Fund, L.P. have filed an updated Schedule 13G/A, disclosing that Redmile and Green collectively report beneficial ownership of 4,311,092 shares of Scholar Rock common stock, representing 3.6% of the class. This ownership is held …

Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?

Two healthcare players, Scholar Rock Holding Corporation (NASDAQ:SRRK) and Novo Nordisk A/S (NYSE:NVO), find their near-term narratives intertwined over manufacturing compliance. One is smoothly navigating a supply chain hurdle ahead of a critical drug approval, while the other just delivered a complicated financial quarter. …

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., August 14, 2026--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the "Company") today announced that the company granted inducement equity awards covering an aggregate of 51,947 shares of its common stock to twelve newly hired employees, consisting of inducement stock options to purchase an aggregate …

12 New Hires Receive 51,947 Scholar Rock Equity Awards

Scholar Rock (NASDAQ: SRRK) announced that it granted inducement equity awards totaling 51,947 shares of common stock to twelve new employees. These awards, which include both stock options and restricted stock units, are part of the company's 2022 Inducement Equity Plan, designed to attract …

Scholar Rock (SRRK) Stock Looks Priced At A Premium Today

SRRK Maintains by JP Morgan -- Price Target Raised to $63.00

JP Morgan maintained an "Overweight" rating for Scholar Rock Holding Corp (SRRK) and raised its price target from $56.00 to $63.00, indicating a positive outlook. Despite this, the company has a low GF Score™ of 29/100 due to profitability and growth concerns, along with …

Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Invus reports 8.0% stake in Scholar Rock (SRRK) through 9.6M shares

Invus Public Equities, L.P. and associated entities have reported an 8.0% beneficial ownership stake in Scholar Rock Holding Corporation (SRRK), totaling 9,575,013 shares of common stock. This is detailed in an amended Schedule 13G filing, which states that the shares were acquired for passive …

Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule

Scholar Rock Holding Corporation announced that the FDA review of its lead drug, apitegromab for spinal muscular atrophy, will proceed solely with its secondary fill-finish facility after an issue with its primary manufacturing site. Despite this change, the company confirmed that the Prescription Drug …

Scholar Education Group Sets Board Meeting to Approve Interim Results and Consider Dividend

Zal het aandeel Van Lanschot Kempen de weerstand van €66,48 doorbreken nu kopers de controle behouden?

Scholastic EVP Sasha Quinton sells $930,342 in company stock

Sasha Quinton, Executive Vice President at Scholastic Corp., sold 22,151 shares of company stock worth $930,342 on August 7, 2026. This transaction included shares to cover option exercise costs and taxes, occurring after the company's stock delivered an 80% return over the past year. …

Engaging In Options Activity, Sasha Quinton Exercises Options Valued At $490K In Scholastic

Sasha Quinton, EVP at Scholastic (NASDAQ: SCHL), exercised stock options for 22,151 shares valued at $490,644, as disclosed in an SEC filing on August 10. This transaction occurred while Scholastic shares were trading down 2.55% at $42.78. The article also provides a financial overview …

Q3 EPS Estimates for Scholar Rock Cut by HC Wainwright

Scholastic Insider Sold Shares Worth $1,200,251, According to a Recent SEC Filing

An insider at Scholastic Corporation recently sold 27,249 shares of the company's Class A Common Stock for a total of $1,200,251. The transaction was disclosed in a Form 4 filing with the SEC. This sale comes amidst other insider transactions and a slight decline …

SRRK Reiterated by Wedbush -- Maintains Price Target at $58.00

Wedbush analyst David Nierengarten has reiterated an 'Outperform' rating for Scholar Rock Holding (SRRK) and maintained a $58.00 price target. Despite this, the company has a low GF Score™ of 29/100, indicating financial weaknesses, particularly in profitability and growth, and shows signs of potential …

Scholar Rock's (SRRK) Outperform Rating Reiterated at Wedbush

Wedbush has reiterated an "Outperform" rating for Scholar Rock (SRRK) with a $58 price target, indicating a potential 12.45% upside. The company is near its 52-week high, and the analyst consensus remains "Buy" with an average target of $56.79. Institutional investors hold a significant …

Scholar Rock Holding (SRRK) Advances Apitegromab Review, Is 11% Undervalued Enough?

H.C. Wainwright reiterates Scholar Rock stock rating at buy

SRRK Reiterated by HC Wainwright & Co. -- Price Target Maintained at $65

HC Wainwright & Co. has reiterated its "Buy" rating for Scholar Rock Holding (SRRK), maintaining a price target of $65.00, suggesting a potential upside of 23% from its current price of $52.97. Despite this positive analyst outlook, the company has a low GF Score™ …

Zal het aandeel Van Lanschot Kempen standhouden op het steunniveau nu het zwakke momentum aanhoudt?

Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

(Updates with day of announcement in first paragraph, Novo Nordisk's affiliation in the second paragraph, and latest stock moves in the fourth paragraph.)Scholar Rock Holding (SRRK) said Friday that the FDA review of its apitegromab Biologics License Application for spinal Silver Upgrade to read …

Scholar Rock Holding Corp (SRRK) Earnings Forecast: Future EPS & Revenue Growth Estimates

Scholastic EVP, pres. CBG Quinton sells $1.2m in stock

Sasha Quinton, EVP and President of the Children’s Book Group at Scholastic Corp (NASDAQ:SCHL), sold approximately $1.2 million worth of company stock after exercising options on August 5 and 6, 2026. These transactions involved acquiring 28,037 shares through options at $20.63 per share and …

Scholastic Corporation (SCHL) Stock Forecasts

Argus has raised its target price for Scholastic Corporation (SCHL) to $46.00, citing its role as an American publishing and education media company. The current stock price for SCHL is $41.98. The full report provides detailed analysis and is available to premium subscribers.

Scholar Rock Holding Corporation (SRRK) Stock Price, News, Quote & History

This article provides a detailed overview of Scholar Rock Holding Corporation (SRRK), including its current stock price, financial data, and company profile. It highlights SRRK's focus on developing treatments for neuromuscular diseases and solid tumors, showcasing its key pipeline products and recent performance metrics …

Scholastic director Kaya Henderson sells $130,812 in company stock

Scholastic director Kaya Henderson sold 3,250 shares of Scholastic Corp (NASDAQ:SCHL) common stock for $130,812 on August 6, 2026, retaining 7,113 shares. This transaction follows Scholastic's recent fiscal fourth-quarter earnings report, which met profit forecasts but missed revenue expectations by approximately 7.9%. Despite the …

Scholastic Corp (SCHL) director sells 3,250 shares at $40.25

Kaya Henderson, a director at Scholastic Corp (SCHL), sold 3,250 shares of Common Stock at $40.25 per share on August 6, 2026. This open market transaction reduced Henderson's direct holdings to 7,113 shares. The sale, valued at $131,000, was reported in an SEC Form …

Scholastic (NASDAQ: SCHL) proxy outlines 2026 CEO pay and bonuses

Scholastic Corporation's definitive proxy statement outlines executive compensation for fiscal year 2026, revealing CEO Peter Warwick's total compensation of $3.74 million, including a $1.10 million STIP bonus. The company plans a virtual annual meeting on September 16, 2026, where shareholders will vote on director …

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

Scholar Rock announced that the FDA review of its apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA) will proceed with a second fill-finish facility, following an Official Action Indicated (OAI) classification for their initial facility, Catalent Indiana. The company expects a potential …

Scholar Rock (SRRK.US) will release its earnings report before the market opens on August 6.

Kan het aandeel Van Lanschot Kempen de weerstand doorbreken nu de kortetermijn-verkoopdruk aanhoudt?

Scholar Rock (NASDAQ:SRRK) Releases Earnings Results, Meets Estimates

Scholar Rock (NASDAQ:SRRK) reported quarterly earnings of ($0.84) per share, meeting analyst estimates, an improvement from ($0.98) per share a year ago. The company's U.S. approval for apitegromab is still targeted for September 30, despite delays in European approval due to FDA classification uncertainties …